European and Developing Countries Clinical Trials Partnership (EDCTP)   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: The Hague Netherlands (2003)

Organization Overview

First Clinical Trial
2006
NCT00334256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

European and Developing Countries Clinical Trials Partnership (EDCTP)

Active Ingredients

Drugs in Phase 4 Trials (4)

bacille calmette-guerin (1 trial)

efavirenz (sustiva) (3 trials)

primaquine (1 trial)

pyridoxine (2 trials)

Drugs in Phase 3 Trials (32)

abacavir (ziagen) (1 trial)

acetylsalicylic acid (aspirin) (1 trial)

albendazole (Albenza) (1 trial)

amodiaquine (camoquin) (1 trial)

artemether (1 trial)

artesunate (4 trials)

atazanavir (reyataz) (1 trial)

cabotegravir (Vocabria) (1 trial)

clindamycin (cleocin) (1 trial)

coartem (2 trials)

dihydroartemisinin (1 trial)

dolutegravir (tivicay) (2 trials)

ethambutol (myambutol) (3 trials)

fexinidazole (1 trial)

isoniazid (nydrazid) (3 trials)

ivermectin (stromectol) (1 trial)

lamivudine (epivir) (4 trials)

lopinavir (Kaletra) (4 trials)

lumefantrine (Coartem) (3 trials)

moxifloxacin (avelox) (3 trials)

piperaquine (1 trial)

prednisone (meticorten) (1 trial)

pyrazinamide (Aldinamide) (3 trials)

pyronaridine (1 trial)

quinine (qualaquin) (1 trial)

raltegravir (isentress) (1 trial)

rifampin (8 trials)

rilpivirine (edurant) (1 trial)

ritonavir (Norvir) (3 trials)

sulfadoxine (1 trial)

tenofovir (viread) (2 trials)

zidovudine (retrovir) (2 trials)

Drugs in Phase 2 Trials (21)

ad35-grin (1 trial)

aeras-402 (1 trial)

amoxicillin (1 trial)

bedaquiline (sirturo) (1 trial)

btz-043 (1 trial)

chad63 (3 trials)

cilexetil (1 trial)

cipargamin (1 trial)

clavulanate (Augmentin) (1 trial)

delamanid (1 trial)

emtricitabine (emtriva) (1 trial)

fozivudine tidoxil (1 trial)

Ganaplacide (1 trial)

gbs-nn/nn2 (1 trial)

midazolam (versed) (1 trial)

mva85a (1 trial)

mva.hiva (2 trials)

mva me-trap (6 trials)

psg2.hivconsv dna vaccine (1 trial)

sq109 (2 trials)

sutezolid (1 trial)

Drugs in Phase 1 Trials (14)

afo-18 (1 trial)

chad63 me-trap (3 trials)

chadox1.thivconsv1 (1 trial)

detoxified shigella flexneri 2a artificial invasin complex (1 trial)

dmlt (1 trial)

hdcrv (1 trial)

hivis dna vaccine (1 trial)

matrix m1 (1 trial)

mva-cmdr (1 trial)

mva.thivconsv3 (1 trial)

mva.thivconsv4 (1 trial)

r21 (1 trial)

rh5.1 (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (2)

killed oral cholera vaccine (1 trial)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

HIV Infections (Phase 3)

Immune Reconstitution Inflammatory Syndrome (Phase 3)

Immunologic Deficiency Syndromes (Phase 3)

Malaria (Phase 4)

Malaria, Falciparum (Phase 3)

Meningitis (Phase 3)

Streptococcal Infections (Phase 2)

Syndrome (Phase 3)

Trypanosomiasis (Phase 3)

Trypanosomiasis, African (Phase 3)

Tuberculosis (Phase 4)

Tuberculosis, Meningeal (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 49
  • # of Trial APIs: 73